Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Healthcare Informatics : the Business Magazine for Information and Communication Systems
|
February 23, 2012
Cardiovascular information systems
Joe Marion
Statistics in Medicine
|
May 14, 2022
Bayesian model of disease progression in mucopolysaccaridosis IIIA
Joe Marion, Juan Ruiz, Benjamin R Saville
Pharmaceutical Statistics
|
April 27, 2024
Optimal sample size division in two-stage seamless designs
Lindsay R Berry, Joe Marion, Scott M Berry, et al.
Drugs
|
October 26, 2022
Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Recurrent Clostridioides difficile Infection
Sahil Khanna, Maha Assi, Christine Lee, et al.
Drugs
|
November 7, 2022
Correction to: Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Recurrent Clostridioides difficile Infection
Sahil Khanna, Maha Assi, Christine Lee, et al.
BMJ Open
|
August 7, 2023
Platform adaptive trial of novel antivirals for early treatment of COVID-19 In the community (PANORAMIC): protocol for a randomised, controlled, open-label, adaptive platform trial of community novel antiviral treatment of COVID-19 in people at increased risk of more severe disease
Oghenekome Gbinigie, Emma Ogburn, Julie Allen, et al.
Lancet (London, England)
|
December 25, 2022
Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial
Christopher C Butler, F D Richard Hobbs, Oghenekome A Gbinigie, et al.
JAMA
|
December 10, 2024
High-Flow Nasal Oxygen vs Noninvasive Ventilation in Patients With Acute Respiratory Failure: The RENOVATE Randomized Clinical Trial
, Israel S Maia, Letícia Kawano-Dourado, et al.
JAMA Network Open
|
February 17, 2025
Efficacy and Safety of Zilucoplan in Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial
Sabrina Paganoni, Christina N Fournier, Eric A Macklin, et al.
JAMA
|
March 11, 2025
Pridopidine in Amyotrophic Lateral Sclerosis: The HEALEY ALS Platform Trial
, Jeremy M Shefner, Björn Oskarsson, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Healthcare Informatics : the Business Magazine for Information and Communication Systems
|
February 23, 2012
Cardiovascular information systems
Joe Marion
Statistics in Medicine
|
May 14, 2022
Bayesian model of disease progression in mucopolysaccaridosis IIIA
Joe Marion, Juan Ruiz, Benjamin R Saville
Pharmaceutical Statistics
|
April 27, 2024
Optimal sample size division in two-stage seamless designs
Lindsay R Berry, Joe Marion, Scott M Berry, et al.
Drugs
|
October 26, 2022
Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Recurrent Clostridioides difficile Infection
Sahil Khanna, Maha Assi, Christine Lee, et al.
Drugs
|
November 7, 2022
Correction to: Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Recurrent Clostridioides difficile Infection
Sahil Khanna, Maha Assi, Christine Lee, et al.
BMJ Open
|
August 7, 2023
Platform adaptive trial of novel antivirals for early treatment of COVID-19 In the community (PANORAMIC): protocol for a randomised, controlled, open-label, adaptive platform trial of community novel antiviral treatment of COVID-19 in people at increased risk of more severe disease
Oghenekome Gbinigie, Emma Ogburn, Julie Allen, et al.
Lancet (London, England)
|
December 25, 2022
Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial
Christopher C Butler, F D Richard Hobbs, Oghenekome A Gbinigie, et al.
JAMA
|
December 10, 2024
High-Flow Nasal Oxygen vs Noninvasive Ventilation in Patients With Acute Respiratory Failure: The RENOVATE Randomized Clinical Trial
, Israel S Maia, Letícia Kawano-Dourado, et al.
JAMA Network Open
|
February 17, 2025
Efficacy and Safety of Zilucoplan in Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial
Sabrina Paganoni, Christina N Fournier, Eric A Macklin, et al.
JAMA
|
March 11, 2025
Pridopidine in Amyotrophic Lateral Sclerosis: The HEALEY ALS Platform Trial
, Jeremy M Shefner, Björn Oskarsson, et al.
Page
of 1